In humans, the selective depletion of CD8+ cells may prevent GVHD after allogeneic transplantation. These cells can infiltrate and damage target tissues. It is of interest to investigate the phenotypical characteristics and cytotoxic properties of the different CD8+ subsets in cGVHD patients. In a preliminary study we found that patients with cGVHD had a markedly elevated percentage of peripheral blood CCR7-/CD45RA+ cells compared to patients without cGVHD; conversely, the CCR7+/CD45RA+ subsets of CD8+ cells was significantly decreased. In this study, we report in depth on the phenotype of effector T cell subsets in cGVHD patients, as well as their proliferative capability, cytotoxic properties and cellular turnover. We confirm a predominance of effector T cell subsets in cGVHD patients and show that a large fraction of these cells down-regulate CCR7 and re-express CD45RA, thus approaching end-stage differentiation. Moreover CD8+ cells of cGVHD patients have low CD8 coreceptor expression, reduced proliferative potential and a high content of perforin and granzyme A. They also have a lower cell turnover and have more propensity to apoptosis, as demonstrated by BrdU incorporation. Taken together, our findings indicate a perturbation of the balance between naive/memory and effector/ CD45RA+CD8+ T cells, and suggest an involvement of the latter compartment characterized by a high content of cytotoxic equipment, in the pathogenesis of cGVHD.
preponderance of CD4+ effector memory cells (CCR7-/CD62Uow, CD4 EM).
Comparatively, less is known about the distribution of CD8+ T cells amongst the different subsets, determined on the basis of the expression of CCR7 and CD45RA markers. Therefore, it is of interest to investigate the phenotypical characteristics and functional properties of the different CD8+ subsets in cGVHD patients.
Human CD8+ T cells can be divided into at least four major different subsets according to their phenotype and functions (6) : naive (T . , CCRJ+/ naive CD45RA+) and central memory (TCM' CCR7+/ CD45RA-) T cells display high proliferative potential and lack immediate effector functions; effector memory (T EM, CCR7-/CD45RA-) and CD45RA+/ effector memory (TEMRA' CCR 7-/CD45RA +) T cells exhibit low proliferative capacities but are able to migrate to extra-lymphoid sites, to produce cytokines and to exert cytotoxic activity.
Central memory T cells have a greater capacity than TEM to persist in vivo and have the ability to differentiate in an antigen-independent fashion into TEMRA cells. The lineage relationship between TCM and TEM and their ability to persist in vivo are not well understood yet, but some authors demonstrated that TEM convert to TCM following antigen clearance; therefore, TCM and TEM do not necessarily represent distinct subsets but a part of a continuum in a linear naive-effector-TEM-T cM differentiation pathway (7) .
In a preliminary study we found that patients with cGVHD had markedly elevated percentages of peripheral blood CCRnCD45RA+ cells as compared to patients without cGVHD (8) , while the CCRJ+/CD45RA+ subset of CD8+ cells was significantly decreased. Moreover, we found that, in cGVHD male patients who received transplant from HLA-identical female sibling, the vast majority of CD8+ cells specific for the minor histocompatibility antigen (mHag) H-Y+ consisted ofCCRnCD45RA+ cells, suggesting a skewed distribution of H-Yspecific CD8+ cell subsets.
In this study we confirm a predominance of effector T cell subsets in cGVHD patients and show that a large fraction of these cells down-regulate CCR7 expression and re-express CD45RA, thus approaching end-stage differentiation. Moreover, experiments indicate that CD8+ cells of cGVHD patients have low CD8 coreceptor expression, reduced proliferation attitude and a high content of perforin and granzyme A. They also have a lower cell turnover and have more propensity to apoptosis, as demonstrated by BrdU incorporation.
MATERIALS AND METHODS

Patients
A total of24 adult patients treated by allogeneic HSCT for hematologic malignancies were recruited for the study (Table I) . All patients received peripheral blood stem cells (PBSCs) transplanted from HLA-identical donors, and of these, 12 patients (4 females, 8 males, mean age: 56, age range: 49-68) had cGVHD and 12 patients (3 females, 9 males, mean age: 52, age range: 41-66) had no current cGVHD. Amongst the patients with cGVHD, 4 had extensive and 8 had limited disease. Few patients with cGVHD had a history of antecedent aGVHD; all required immunosuppressive treatment at the time of sampling. Two other groups were also recruited as control groups: the first consisted of 10 healthy subjects (HS, 4 females, 6 males, mean age: 55, age range: 40-68), while the second consisted of 10 patients who had undergone kidney transplantation (KT, 6 females, 4 males, mean age: 54, age range: 45-60) and required treatment with immunosuppressive drugs, in order to evaluate the impact of these drugs on CD8+ T cell distribution in subsets. Patients were excluded if they had current CMV or other infections.
Acute and chronic GVHD were diagnosed and graded in all patients according to standard criteria (9) . cGVHD patients were recruited for this study only after at least 100 days from the allogeneic HSCT. All patients provided written informed consent and the study was performed in accordance with research protocols approved by the Institutional Review Board.
Cell culture andflow cytometry
Fresh human peripheral blood mononuclear cells (PBMCs) were isolated from buffy coat of healthy donors or patients by Ficoll-Hypaque (Pharmacia Biotech) density centrifugation. All cell culture experiments were performed 'in RPMI 1640 medium (Euroclone) supplemented with 10% FCS (Invitrogen Life Technologies), 2 mM L-glutamine, 20 nM HEPES and 100 Vlml penicillin/streptomycin. Cells were stained with quantum-red (QR)-conjugated or fluorescein isothiocyanate (FITC)-conjugated anti-human CD3 and CD8 mAbs (Sigma), phycoerythryn (PE)-conjugated anti-human CCR7 mAb, FITC-conjugated anti-human CD45RA mAb, PE-conjugated anti-human granzyme A mAb and FITC-conjugated anti-human perforin mAb, all from BD Biosciences.
The manufacturer's protocol was followed for the CD3, CDS, CCR7 and CD45RA mAbs. To determine granzyme A and perforin expression, cells were washed twice with cold PBS (pH 7.2) and fixed with PBS/2% paraformaldehyde for 10 min at 4°C, after surface staining with anti-CDS mAb. Fixation was followed by permeabilization with permeabilizing solution (BD Biosciences). The permeabilizing solution was used for the subsequent incubation with the mAbs. Intracellular content of perforin and granzyme A was measured in freshly isolated CDS+ cells without previous stimulation.
Flow cytometry was performed using either FACSCan or FACSCalibur flow cytometers (BD Biosciences) and data analysis was carried out with CellQuest software.
CFSE-proliferation assay
Fresh PBMCs obtained from patients and healthy subjects were washed twice with PBS and incubated for 10 minutes at 37°C with 2.5 IlM CFSE (Vinci-Biochem). Cells were washed once with FCS, then two times with PBS, resuspended in complete culture medium to a final concentration of 1 x 10 6 cells/ml and cultured with 1 ug/ml PHA for 72 h at 37°C. CDS+ T cells were sorted by positive selection using the MACS system (Miltenyi Biotec). In brief, PBMCs (10 7 cells/SO III incubation buffer; PBS12% FCS/5 mM EDTA) were incubated with anti-CDS microbeads for 15 min at 4°C. After one washing, cells were resuspended in incubation buffer and enrichment was performed with MACS columns according to the manufacturer's instructions. The resulting CDS+ T cells were >95% CDS+/ CD3+, as determined by immunofluorescence analysis with directly labelled mAbs.
Cell cycle analysis
Freshly isolated PBMCs were incubated with 10 IlM 5-Bromo 2-Deoxyuridine (BrdU, BD Pharmingen) for 20 h in RPMI supplemented with 10% FCS. At the end of the incubation period, FITC-conjugated anti-CDS mAb was added in 50 III of staining buffer. Cells were then fixed, permeabilized, treated with DNase (300 ug/ml, final concentration) and stained with APC-conjugated anti-BrdU antibody. Finally, the 7-amino-actinomycin D (7-AAD) solution was added to stain total DNA for cell cycle analysis. The stained cells were analyzed by flow cytometry.
Statistical analysis
Box plot analysis of sample distributions was used where applicable. Two-group comparisons were done by the Student's t-test. A p value less than 0.01 was considered statistically significant. Only statistical significant differences are annotated in the graphs. Data were analyzed using statistical software SYSTAT 11 (Systat Software).
RESULTS
Increase ofCCR7-CD45RA+ CD8+ T cells in cGVHD patients
We analyzed CCR7 and CD45RA expression on CD8+ T cells from 24 patients who received bone marrow transplantation from HLA-identical sibling, with and without cGVHD, and from healthy subjects (HS); we also analyzed CD8+ T cell subsets in patients who underwent kidney transplantation (KT) to evaluate the effect of the immunosuppressive drugs. Absolute numbers and percentages of total T lymphocytes and their CD8+ subsets did not differ significantly between PBMC of healthy subjects and bone marrow transplanted patients, irrespective of whether they did or did not develop cGVHD.
As illustrated in Fig. 1 , analysis of CCR7 and CD45RA expression on CD8+ T cells showed a significant reduction of the percentage of naive cells (CCR7+CD45RA+) in patients with cGVHD (12.5% ± 5.7) compared to patients without cGVHD (31.3% ± 17.4, p = 0.008), KT patients (34.3% ± 19.3, p = 0.006) and HS (35.1% ± 16.2, P = 0.008). Percentages of T CM and T EM did not show statistically significant differences between all tested groups, although cGVHD patients showed a lower percentage of TCM cells. Patients with cGVHD had statistically significant higher numbers ofTEMRA cells (55% ± 14), compared to patients without cGVHD (26 ± 20,p = 0.003), KT patients (30 ± 18,p = 0.004) and HS (24 ± ll,p = 0.005).
In order to study CD8+ T cell subset distribution over time, we collected blood samples of. some patients at different time points after transplant and assessed the percentage of these subsets at each time point. A representative graph of 5 patients with cGVHD is shown in Fig. 2 .
CD8+ T cells from cGVHD patients have reduced proliferative potential but increased expression of . perforin and granzyme A
To assess the proliferative potential of CD8+ T cells from patients with cGVHD, a CFSEproliferation assay was performed. While CD8+ cells of HS and transplanted patients without cGVHD underwent several proliferative cycles, with typically six division cycles, the proliferative potential of CD8+ T cells from cGVHD patients was very low, with typically only one or two proliferative cycles (Fig. 3A) . However, the low proliferative ability of CD8+ T cells of almost all cGVHD patients was accompanied by an increased intracellular expression of perforin and granzyme A: the percentage of CD8+ perforin" cells was 38.8% ± 15.4 in cGVHD patients, 12.5% ± 5.9 in patients without cGVHD and 10.4% ± 5.4 in HS. Similarly, the percentage of CD8+ granzyme A+ cells was 33% ± 8.9 in cGVHD patients, 7.7% ± 4.5 in patients without cGVHD and 9.1% ± 5 in HS. Fig. 3B shows FACS staining for perforin and granzyme A of CD8+ T cells from one representative HS patient, one patient without GVHD and one with cGVHD. Taken together, these results show that CD8+ T cells from cGVHD patients have a skewed phenotype characterized by the predominance of TEMRA cells and a low proliferative potential, but they are enriched in perforin and granzyme A content, suggesting they are well equipped with cytotoxic capability.
cGVHD patients have a high fraction of CD45RA+CCR7-T EMRA cells with a low CD8 expression and a high content of perforin and granzymeA
FACS analysis on freshly isolated PBMC from all HSCT patients, both with and without cGVHD, reveals the presence of two subsets of CD8+ T cells with distinct levels of CD8 expression. This pattern 
. Phenotypic analysis of CD8+ T cells subsets. Box plots showing the percentage ofnaive, central memory (TcJ, effector memory (T EM ) , and CD45RA+ effector memory (T EMR ) CD8+ T cells in healthy subjects, patients without GVHD (no GVHD), kidney transplantation (KT) patients and patients with cGVHD (cGVHD). The top and bottom lines correspond to the 75 th and 25 th percentiles, respectively. The bars on the bottom and top extend from the minimum value and maximum value, respectively. The dotted lines connect the mean, the continuous lines connect the median. Only significantly different p values are shown.
was only occasionally found also in PBMC from HS. Previous studies demonstrated that CD8 expression is not a static property, but can be modulated to regulate the sensitivity of the responding T cell (10) . Thus, our analysis indicated that while the CD8 high population was predominant in PBMC of HS and patients without cGVHD, CD8+ T cells from cGVHD patients mainly had a CD8 10w phenotype (Fig. 4A ). Multiparametric FACS analysis (Fig. 4B ) revealed that CD8 high T cells mainly consist of T . naive (CD45RA+CCRr) and T CM cells (CD45RA'CCR7+) cells, while CD8 10w T cells are mainly TEM (CD45RA CCRn and T EMRA (CD45RA+CCRn cells, irrespective of whether they were obtained from HS or transplanted patients with or without cGVHD. CD8 high and CD8 10w T cells of cGVHD patients were further analyzed by functional comparison. Analysis (Fig. 4C ) showed that CD8 Jow cells had higher content of granzyme and perforin than CD8 high cells; conversely, CD8 high cells showed a consistent proliferative response to PHA stimulation with several division cycles, whereas in the CD8 Jow population the response was faint (Fig. 4D) . Thus, cGVHD patients show an expanded population of TEMRA cells low CD8 expression and proliferative attitude, but with a predominant cytotoxic potential, as suggested by high levels of perforin and granzyme.
Ex vivo turnover of CD8 high and CD8'ow cell subsets in cGVHD patients
Previous studies have demonstrated that the CD8 10w phenotype defines a stable population that arises after repeated antigen encounter in vivo, having implications in the maintenance of tolerance and memory (10) . Using BrdU incorporation to assess the in vivo turnover of CD8+ T cells, it has been shown that TeM and TEMRA cells had, respectively, the highest and the lowest turnover among memory cells. To gain insight into the observed phenotypic distribution, we performed a BrdU-incorporation assay to assess the ex vivo turnover of CD8 high and CD8 10w subpopulations, during a 20-h culture period.
We incubated PBMCs of one patient with cGVHD, one without cGVHD and a HS with BrdU; part of the cells was stimulated with PHA. At the end of the incubation period, we analyzed the distribution of CD8 high and CD8 10w cells into cell cycle, based on 7AAD and BrdU incorporation. In all subjects, we observed different distribution of the CD8 high and CD8 10w subsets among cell cycle phases, independently from PHA stimulation.
The CD8 high population contained a large fraction of cells in the S phase, while the remaining CD8 high cells were distributed between the Go/G 1 and G2/M phases. There were no CD8 high cells into the apoptotic phase. Conversely, the CD8 10w population contained few CD8+ cells in the S phase and a large fraction was apoptotic (Fig. 5) .
These results further support the view that the increased CCR7-/CD45RA+CD8 10w cells in cGVHD patients are typical TEMRA cells with low replicative potential, high cytotoxic potential and high propensity to apoptotic death.
DISCUSSION
Zhang and co-workers have recently demonstrated in mice models that host thymus is not required for induction of cGVHD and that quiescent T cells in the transplants may be activated and expanded to cause cGVHD in allogeneic recipients (11). Other recent studies (12) in mice models of cGVHD confirmed that there is a persistent alloreactive CD8+population that is able to homeostatically survive in response to IL-7 and IL-15 and is composed by effector memory CD8+ cells as dominant population. The individual roles of CD4+ and CD8+ T cells in GVHD have been exhaustively studied in mouse models (13) (14) (15) (16) (17) (18) , suggesting that these cells may induce tissue injury (19) . In nearly all miHA-mismatched models, CD8+ T cells contribute to GVHD together with CD4+ T cells (20) (21) . In humans, the selective depletion of CD8+ cells may prevent GVHD after allogeneic transplantation. Also, in MHC-matched CD8+ T-cell-mediated cGVHD, cognate interactions of these cells with target tissue are absolutely necessary (12) , and consequently expanded alloreactive cells can infiltrate and damage target tissues.
. Proliferative capacity of CD8+ T cells subsets and expression of cytotoxic molecules. A) Representative histogram plots ofsorted CD8+ T cells stained with CFSE and stimulated with PHA in two healthy subjects (HS), two patients without GVHD (no GVHD) and with cGVHD (cGVHD). Numbers above the markers indicate the frequency of non-proliferating cells. B) Representative dot plots showing CD8+ perforin: and CD8+ GranA+frequencies in healthy subjects (HS), patients without (no GVHD) and with GVHD (cGVHD
In this study we confirm the increase of TEMRA CD8+ cells in cGVHD patients receiving allogeneic transplantation and we suggest that the increase of the TEMRA CD8+ T cells subset is a peculiarity of cGVHD and is not an effect of immunosuppressive drug administration.
Since the percentage and the absolute number of CD8+ T cells was not significantly modified in each group of patients and the increase in the percentage of TEMRA subset was paralleled by a conspicuous decrease of the naive subset, we can speculate that in cGVHD there is a progressive differentiation from naive to TEMRA cells in presence of an unrelenting allogeneic or IL-15 stimulation. In fact, it is known that TEMRA cells can be generated by IL-15-stimulated TCM cells even in the absence of antigen (7) . Furthermore, the abundance in TEMRA cells could reflect elevated levels of interleukin-l S (IL-15) present in the serum of cGVHD patients that received hematopoietic stem cell transplantation (22) . It is known that responsiveness to IL-15 is elevated in effector memory TEMRA cells that express elevated levels of IL-15Ra for their maintenance and homeostatic proliferation (7) . In support of such a possibility, in vivo activation and expansion of human T lymphocytes in response to IL-15 causes exacerbation of human T cell-mediated xenogeneic GVHD (23) .
To gain insight into the functional properties of CD8+ cells from transplanted patients, we stimulated these cells to proliferate, and observed a very low proliferative response in cGVHD patients, associated with an high intracellular content ofboth perforin and granzyme A, compared to patients without cGVHD and healthy subjects. This suggests an intrinsic aging of these cells and, probably, a propensity to .cell death. Consistent with this possibility, CD8+ T cells of cGVHD patients have a cytotoxic equipment typical of end-stage terminally differentiated effector cells (24) . Accordingly, TEMRA cells are the most differentiated type of memory cells. They have high susceptibility to apoptosis and express high levels of cytotoxic molecules such as perforin and Fas ligand. Furthermore, TEMRA cells can be obtained from a TCM subset upon cytokine stimulation and require homeostatic proliferation in the absence of antigen (25) .
It was also of interest to analyze the level of CD8 expression on CD8+ cells in transplanted patients. The level of CD8 coreceptor has been shown to be inversely correlated to the concentration of the peptide used for the primary stimulation, with higher concentrations of antigen resulting in lower expression of CD8 (26)). Thus, it has been proposed that CD8 cell surface expression is not a static property, but can be modulated to finely tune the sensitivity of the responding CTL. These cells are also implicated in the maintenance of tolerance and memory. CD8 10w T cells also have a much reduced ability to proliferate, produce TcI-type cytokines and lyse target cells in response to cognate antigen (27) (28) , and are possibly analogous to stable CD8 10w T cells generated in vitro after antigen stimulation in the presence of IL-4 (29) (30) .
The results here reported reveal that the CD8+ cells from cGVHD patients mainly have a CD8'oW phenotype, largely consisting of TEM and TEMRA cells equipped with a high content of perforin and granzyme, and that these cells have the lowest turnover among CD8+memory cells. These findings, together with the observation that only few cells were in the S phase, while most of them were in the apoptotic phase, suggest that this population is composed by end-stage effector cells that had repeatedly encountered the antigen during the primary phases of the disease.
The properties of the CD45RA+/CCR7-subset here described are different from those of EBV lytic epitope-specific CD45RA+CD8+ cells which emerge after the resolution of the infection (31) . In fact, the latter cells re-expressing the CD45RA molecule also express perforin and display cytotoxic activity, but they are specifically activated to proliferate and resist to apoptosis. This suggests that they are a stable, non-cycling pool of memory cells rather than end-stage effector cells. Probably the in vivo generation and maintenance of the CD8+ effector subset studied by us would require the persistence of host alloantigens during the GVHD process.
Further studies to evaluate the expression of other phenotypic markers such as CD28 and CD27 are necessary to better characterize the CD8'ow population present in cGVHD patients and determine its location into the differentiation pathway from naive to terminally differentiated effector T CD8+ cells. At present, our findings indicate a perturbation of the balance between naive/memory and effector/ CD45RA+CD8+T cells and suggest an involvement of the latter compartment, characterized by a high content of cytotoxic equipment, in the pathogenesis ofcGVHD.
